Daiichi Sankyo’s Asubio Pharma Allocates $102 Million To Research Plant
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo subsidiary Asubio Pharma plans to spend $102 million to build a research facility near Kobe. Asubio planned the facility to be located near the world's fastest supercomputer expected to be available next year. The Daiichi Sankyo subsidiary already specializes in bio-based treatments for various ailments. Its facility is to be among one of 130 drug research and development facilities on Kobe's Port Island. (Click here for more - a subscription may be required